NPCE
NeuroPace is a medical device company that develops the RNS System, a neuromodulation technology for epilepsy. The system provides personalized, responsive treatment by detecting abnormal brain activity and delivering stimulation to reduce seizures, while collecting EEG data to help clinicians optimize care. It targets adults with drug‑resistant focal epilepsy and supports engagement with epilepsy centers, patients, and providers worldwide. Based in the United States, NeuroPace positions itself as a leader in epilepsy treatment through data-driven insights and patient-centered outcomes.
No recent news for this company.
No recent deals for this company.